Kouvari M, Chrysohoou C, Aggelopoulos P, Tsiamis E, Tsioufis K, Pitsavos C, Tousoulis D
First Cardiology Clinic, School of Medicine, University of Athens, Athens, Greece.
Department of Nutrition Science - Dietetics, Harokopio University, Athens, Greece.
Eur J Clin Nutr. 2017 Aug 23. doi: 10.1038/ejcn.2017.122.
BACKGROUND/OBJECTIVES: Nutrition in secondary prevention of Acute Coronary Syndrome (ACS) is inadequately investigated. We sought to evaluate the role of Mediterranean diet in prognosis of first-diagnosed ACS patients, according to heart failure type.
SUBJECTS/METHODS: in 2006-2009, 1000 consecutive patients hospitalized at First Cardiology Clinic of Athens with ACS diagnosis were enrolled in the study. In 2016, 10-year follow-up was performed (75% participation rate). Only n=690 (69%) first-diagnosed ACS patients were included. Adherence to Mediterranean diet was assessed through MedDietScore (range 0-55). Heart failure phenotypes were reduced, mid-range and preserved ejection fraction (that is, HFrEF, HFmrEF and HFpEF, respectively).
Ranking from first to third MedDietScore tertile, fewer 1, 2 and 10-year fatal/non-fatal ACS events were observed. Multivariate logistic regression analysis highlighted a significantly inverse association between MedDietScore and long-term ACS prognosis in 1 year (odds ratio (OR)=0.84, 95% confidence interval (CI) (0.71, 1.00), P=0.05), 2 year (OR=0.91, 95% CI (0.82, 1.00), P=0.04) and 10 year (OR=0.93, 95% CI (0.85, 1.00), P=0.05) follow-up. Further analysis revealed that MedDietScore differentially affected patients' prognosis according to heart failure phenotype, with short-term impact in HFrEF and HFmrEF patients yet longer positive outcomes in HFpEF and C-reactive protein potentially mediated these relations.
Mediterranean diet seemed to protect against recurrent cardiac episodes in coronary patients with major ACS complications. Results were more encouraging with regard to patients with preserved left ventricle function. Such findings may possess a cost-effective, supplementary-to-medical, treatment approach in this patient category where evidence concerning their management are inconclusive.European Journal of Clinical Nutrition advance online publication, 23 August 2017; doi:10.1038/ejcn.2017.122.
背景/目的:急性冠状动脉综合征(ACS)二级预防中的营养状况研究尚不充分。我们试图根据心力衰竭类型评估地中海饮食在初诊ACS患者预后中的作用。
受试者/方法:2006年至2009年,连续1000例在雅典第一心脏病诊所因ACS诊断住院的患者纳入本研究。2016年进行了10年随访(参与率75%)。仅纳入n = 690例(69%)初诊ACS患者。通过地中海饮食评分(范围0 - 55)评估对地中海饮食的依从性。心力衰竭表型为射血分数降低、中等范围和保留(即分别为HFrEF、HFmrEF和HFpEF)。
从地中海饮食评分三分位数的第一到第三,观察到的1年、2年和10年致命/非致命ACS事件较少。多因素逻辑回归分析显示,在地中海饮食评分与1年(比值比(OR)= 0.84,95%置信区间(CI)(0.71,1.00),P = 0.05)、2年(OR = 0.91,95% CI(0.82,1.00),P = 0.04)和10年(OR = 0.93,95% CI(0.85,1.00),P = 0.05)随访的长期ACS预后之间存在显著的负相关。进一步分析表明,地中海饮食评分根据心力衰竭表型对患者预后有不同影响,对HFrEF和HFmrEF患者有短期影响,而对HFpEF患者有更长的积极结果,并且C反应蛋白可能介导了这些关系。
地中海饮食似乎可预防患有主要ACS并发症的冠心病患者再次发生心脏事件。对于左心室功能保留的患者,结果更令人鼓舞。在这类管理证据尚无定论的患者中,这些发现可能具有一种经济有效的辅助医疗治疗方法。《欧洲临床营养学杂志》2017年8月23日在线优先发表;doi:10.1038/ejcn.2017.122 。